Wedmont Private Capital’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$403K Sell
1,979
-230
-10% -$47.7K 0.01% 636
2026
Q1
$510K Buy
2,209
+26
+1% +$6.48K 0.02% 489
2025
Q4
$542K Buy
2,183
+57
+3% +$14.6K 0.02% 442
2025
Q3
$602K Buy
2,126
+28
+1% +$7.65K 0.02% 405
2025
Q2
$537K Buy
2,098
+121
+6% +$28.9K 0.02% 408
2025
Q1
$423K Sell
1,977
-55
-3% -$12.8K 0.02% 426
2024
Q4
$475K Buy
2,032
+52
+3% +$12.5K 0.03% 391
2024
Q3
$460K Buy
1,980
+169
+9% +$37.8K 0.03% 378
2024
Q2
$371K Buy
1,811
+111
+7% +$22.5K 0.02% 426
2024
Q1
$330K Buy
1,700
+104
+7% +$19.1K 0.02% 435
2023
Q4
$276K Buy
+1,596
New +$245K 0.02% 447
2023
Q3
Sell
-1,837
Closed -$408K 528
2023
Q2
$408K Buy
1,837
+102
+6% +$22.7K 0.04% 296
2023
Q1
$385K Sell
1,735
-80
-4% -$17.4K 0.05% 271
2022
Q4
$379K Sell
1,815
-1,402
-44% -$308K 0.06% 274
2022
Q3
$702K Buy
3,217
+1,656
+106% +$377K 0.14% 117
2022
Q2
$327K Buy
+1,561
New +$332K 0.07% 216

Other funds holding RMD

Wedmont Private Capital's RMD Position: Q2 2026 in Review

Wedmont Private Capital reduced its ResMed (RMD) stake by 10% in Q2 2026, selling an estimated $47.7K and leaving 1,979 shares worth $403K. The position accounts for 0.01% of the portfolio, ranked #636.

Wedmont Private Capital first reported a position in RMD in Q2 2022 and has held it in 16 quarters since. The position peaked at $702K in Q3 2022. 155 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Wedmont Private Capital held 1,979 shares of ResMed worth $403K as of Q2 2026.
  • Wedmont Private Capital sold 230 ResMed shares in Q2 2026, an estimated $47.7K.
  • ResMed made up 0.01% of Wedmont Private Capital's portfolio in Q2 2026, its #636 holding.
  • Wedmont Private Capital first reported a position in ResMed in Q2 2022 and has held it in 16 quarters since.
  • Wedmont Private Capital's ResMed position peaked at $702K in Q3 2022.
  • 155 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.